bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Each year, more than 700,000 people lose their lives to drug-resistant infections, and this number could climb to 10 million by the year 2050 if nothing is done help combat it. Now, the COVID-19 pandemic is exacerbating the problem.
Dr. Septimus will discuss the potential benefits and harms of antibiotics, as well as the value of antimicrobial stewardship when it comes to improving outcomes of patients suffering from sepsis.
Clinical presentation of kidney involvement from COVID-19 can range from mild proteinuria to progressive AKI, requiring renal replacement therapy (RRT).
Administering antimicrobial therapy is essential for treating the underlying infections that cause sepsis, but the protocols for doing so can, at times, clash with antimicrobial stewardship guidelines.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...